Toxic Epidermal Necrolysis in Pregnancy: A Case Report

Anisha Choudhary1, Murari Bharadwaj2, Archana Barik1

  • 1Obstetrics and Gynecology, Tata Main Hospital, Jamshedpur, IND.

Cureus
|February 16, 2026
PubMed

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe mucocutaneous adverse drug reactions associated with significant morbidity and mortality. SJS or TEN during pregnancy is rare and presents with unique diagnostic and management challenges, with potential risks to both the mother and fetus. We report a case of a 25-year-old primigravida at 29 weeks of gestation who presented with widespread cutaneous eruptions following ingestion of an over-the-counter herbal medication for headache. Clinical examination revealed extensive erythematous macules involving the face, trunk, limbs and genital region. Based on characteristic clinical features, extent of epidermal detachment, and temporal association with drug exposure, a diagnosis of TEN was established. The patient went into spontaneous preterm labor and delivered a male neonate vaginally. Multidisciplinary management with systemic corticosteroids and supportive care resulted in gradual clinical improvement and complete re-epithelialization. Both the mother and neonate had favorable outcomes. This case highlights the importance of early clinical recognition of TEN in pregnancy and emphasizes that even herbal and alternative medications may precipitate severe cutaneous adverse reactions. Prompt withdrawal of the offending agent, multidisciplinary supportive care, and individualized obstetric management are essential to optimize maternal and fetal outcomes.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
248
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
245
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
195